Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-18-000187
Filing Date
2018-02-05
Accepted
2018-02-05 16:55:23
Documents
1
Period of Report
2018-02-02

Document Format Files

Seq Description Document Type Size
1 form4-02052018_010209.html 4  
1 form4-02052018_010209.xml 4 4037
  Complete submission text file 0001415889-18-000187.txt   5505
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Singh Shawn (Reporting) CIK: 0001412071 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 18574922